Suven Life Sciences Ltd, a Hyderabad based pharma company, recently received grant of two product patents from Indian Patent Office for New Chemical Entities (NCEs). These two product patents are of the molecules for the treatment of disorders associated with neurodegenerative diseases.
The products will be useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia.With these two patents, Suven has a total of eleven granted Indian patents on NCEs in their portfolio.
No comments:
Post a Comment